NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
SARS-CoV-2 infection of non-human primates
SARS-CoV-2 infection of non-human primates is a funding opportunity from NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, up to 448866.
Overview
SARS-CoV-2 infection has a spectrum of clinical disease outcomes, ranging from asymptomatic to fatal. The severity of COVID-19 is largely determined by the degree of virus-induced damage and immune-mediated pathology. However, the factors that prevent or promote pulmonary inflammation during SARS-CoV-2 infection are…